Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Inari Medical Inc (NASDAQ: NARI) was $55.03 for the day, down -2.01% from the previous closing price of $56.16. In other words, the price has decreased by -$2.01 from its previous closing price. On the day, 1.24 million shares were traded. NARI stock price reached its highest trading level at $56.79 during the session, while it also had its lowest trading level at $54.83.
Ratios:
Our analysis of NARI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 599.94. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 17, 2024, initiated with a Outperform rating and assigned the stock a target price of $75.
On September 18, 2024, Stifel started tracking the stock assigning a Hold rating and target price of $50.
On September 03, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $47.Leerink Partners initiated its Market Perform rating on September 03, 2024, with a $47 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 16 ’24 when Hoffman William sold 60,000 shares for $55.66 per share. The transaction valued at 3,339,704 led to the insider holds 441,233 shares of the business.
MITCH HILL bought 3,000 shares of NARI for $174,630 on Dec 12 ’24. On Dec 10 ’24, another insider, Tu Thomas, who serves as the Chief Medical Officer of the company, sold 4,000 shares for $55.00 each. As a result, the insider received 220,000 and left with 304,036 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NARI now has a Market Capitalization of 3221687296 and an Enterprise Value of 3142871040. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.61 while its Price-to-Book (P/B) ratio in mrq is 7.40. Its current Enterprise Value per Revenue stands at 5.471 whereas that against EBITDA is -120.269.
Stock Price History:
Over the past 52 weeks, NARI has reached a high of $67.10, while it has fallen to a 52-week low of $36.73. The 50-Day Moving Average of the stock is 11.44%, while the 200-Day Moving Average is calculated to be 18.02%.
Shares Statistics:
NARI traded an average of 928.15K shares per day over the past three months and 1313770 shares per day over the past ten days. A total of 58.44M shares are outstanding, with a floating share count of 50.22M. Insiders hold about 14.21% of the company’s shares, while institutions hold 89.44% stake in the company. Shares short for NARI as of 1732838400 were 2916586 with a Short Ratio of 3.14, compared to 1730332800 on 3691725. Therefore, it implies a Short% of Shares Outstanding of 2916586 and a Short% of Float of 6.3.
